WebJan 27, 2024 · Jan 29, 2024. In a report released on January 13, Brian Abrahams from RBC Capital maintained a Buy rating on Incyte (INCY - Research Report), with a price target of $86.00. The company's shares closed last Friday at $80.83.According to TipRanks, Abrahams is a 5-star analyst with an average return of 7.7% and a 49.30% success rate. WebIncyte was the first of the genome science companies to go public. The company made its initial public offering on November 4, 1993, selling 2.3 million common shares at $7.50 on the American Stock Exchange under the ticker symbol IPI. The company would later trade on the NASDAQ under the ticker symbol INCY.
Incyte - Funding, Financials, Valuation & Investors - CrunchBase
WebThe Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial analysts. WebApr 6, 2024 · Ticker Symbol INCY Full Company Profile Financial Performance In 2024, Incyte's revenue was $3.39 billion, an increase of 13.67% compared to the previous year's $2.99 billion. Earnings were $340.66 million, a decrease of -64.09%. Financial Statements Analyst Forecast According to 27 analysts, the average rating for INCY stock is "Buy." gry online farming simulator
INCYTE CORPORATION : INCY Stock Price US45337C1027
WebGet the latest Incyte Corporation (INCY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … Web1 day ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Incyte (INCY) WebStock Ticker Symbol Market Type; Incyte Corporation: INCY: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.64-0.82%: 77.02: 19:59:44: Open Price Low Price High Price final fantasy 6 gba rom deutsch